JSPR compared with EDSA: revenue, margins and what each company keeps, and the suppliers and customers both name

JSPRJasper Therapeutics, Inc.

Mkt capRevenueRevenue

EDSAEdesa Biotech, Inc.

Mkt capRevenueRevenue

Compare

JSPRJasper Therapeutics, Inc.

EDSAEdesa Biotech, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

JSPR, solidEDSA, dashed

Supply-chain overlap

Revenue flow

JSPR: latest quarter not drawable. EDSA: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only JSPR 1

—PCI Pharma Servicesunlistedsupplier

Shared 0

No disclosed counterparties: EDSA.

Only EDSA 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

JSPRJasper Therapeutics, Inc.

0.53▼−1.24%· post 0.53

Mkt cap$14.9M

EDSAEdesa Biotech, Inc.

2.56▼−5.19%· post 2.70

ClosedOct 30 '26

Mkt cap$24.8M

Compare

ClosedOct 30 '26

JSPRJasper Therapeutics, Inc.

EDSAEdesa Biotech, Inc.

0.53▼−1.24%post 0.53

Price

2.56▼−5.19%post 2.70

$14.9M

Mkt cap

$24.8M

JSPR0.53▼−1.24%vsEDSA2.56▼−5.19%ClosedOct 30 '26